| MACULOPATHIE ET AUTRES ANOMALIES | |||||||||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| OD | 24 | 150 | 1 | 16 | 7 | 4 | 202 | ||
| OG | 29 | 140 | 2 | 16 | 6 | 9 | 202 | ||
| OD + OG | 53 | 290 | 3 | 32 | 13 | 13 | 404 | ||
| N/A | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | ||||
| OD | 11,88% | 74,26% | 0,50% | 7,92% | 3,47% | 1,98% | 100,00% | ||
| OG | 14,36% | 69,31% | 0,99% | 7,92% | 2,97% | 4,46% | 100,00% | ||
| MOYENNE | 13,12% | 71,78% | 0,74% | 7,92% | 3,22% | 3,22% | 100,00% | ||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| HOMMES | 9 | 83 | 1 | 10 | 5 | 7 | 115 | ||
| 7,83% | 72,17% | 0,87% | 8,70% | 4,35% | 6,09% | 100,00% | |||
| FEMMES | 6 | 64 | 1 | 8 | 6 | 2 | 87 | ||
| 6,90% | 73,56% | 1,15% | 9,20% | 6,90% | 2,30% | 100,00% | |||
| TOTAL | 15 | 147 | 2 | 18 | 11 | 9 | 202 | ||
| 7,43% | 72,77% | 0,99% | 8,91% | 5,45% | 4,46% | 100,00% | |||
|
|
|||||||||
|
|
|||||||||